David Sharon

David Sharon

AbbVie Inc - Chicago / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4456573
-
person_outline David Sharon's MOST POPULAR ARTICLES
1-) Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress responseD Sharon, S Cathelin, S Mirali, JM Di Trani, DJ Yanofsky, KA Keon, ...Science translational medicine 11 (516), eaax2863, 20191002019
2-) Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasisA Subedi, Q Liu, DM Ayyathan, D Sharon, S Cathelin, M Hosseini, C Xu, ...Cell Stem Cell 28 (10), 1851-1867. e8, 2021532021
3-) The mitochondrial transacylase, tafazzin, regulates AML stemness by modulating intracellular levels of phospholipidsAK Seneviratne, M Xu, JJA Henao, VA Fajardo, Z Hao, V Voisin, GW Xu, ...Cell stem cell 24 (4), 621-636. e16, 2019522019
4-) Disrupting mitochondrial copper distribution inhibits leukemic stem cell self-renewalRP Singh, DV Jeyaraju, V Voisin, R Hurren, C Xu, JR Hawley, ...Cell Stem Cell 26 (6), 926-937. e10, 2020462020
5-) Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphomaP Gelebart, SA Hegazy, P Wang, KM Bone, M Anand, D Sharon, M Hitt, ...Blood cancer journal 2 (8), e82-e82, 2012462012